Myeloproliferative Neoplasms research hub
3 indexed studies · 3 currently recruiting
- recruitingPHASE1
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
This study is testing a new medicine, INCA036978, for people with certain blood conditions called myeloproliferative neoplasms (MPNs). We want to see if it's safe, what dose works best, and if it can be combined with other treatments.
United States · Australia · Belgium - recruitingPHASE1
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
This study looks at a new drug, INCA033989, alone or with ruxolitinib, for blood cancers called myeloproliferative neoplasms. Researchers want to find a safe and effective dose, checking for side effects and how well patients can tolerate the treatment.
Australia · Canada · Denmark - recruitingPHASE1
A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms
This study is looking at a new medicine called INCB160058 for people with certain blood conditions called Myeloproliferative Neoplasms (MPN). Researchers want to see if it's safe, how well people tolerate it, and how it moves through the body.
United States · Canada · France